Flexible and scalable to meet your needs
Easy-to-use COVID-19 testing with minimal lab requirements
Trustworthy, reproducible results
QIAreach SARS-CoV-2 Antigen Test delivers high test sensitivity and specificity, for reliable results you can report with confidence. Test results are determined by objective measurement using proprietary nanoparticle fluorescence technology.Negative Percent Agreement (NPA) vs. high-sensitivity RT-PCR assay
Sample type | Samples tested | Negative results | Negative percent agreement | 95% confidence interval |
---|---|---|---|---|
Anterior nasal swab | 210 | 208 | 99.05% | 96.60 - 99.88% |
Nasopharyngeal swab | 178 | 175 | 98.31% | 95.13 - 99.65% |
Positive Percent Agreement (PPA) vs. high-sensitivity RT-PCR assay
Sample type | Samples tested | Positive results | Positive percent agreement | 95% confidence interval |
---|---|---|---|---|
Anterior nasal swab | 60 | 51 | 85.00% | 73.43–92.90% |
Nasopharyngeal swab | 62 | 50 | 80.65% | 68.63–89.58% |
Digital and connected
QIAreach SARS-CoV-2 Antigen Test provides fast testing on a digital portable device for ease of use, reliability and integrated data management without the need for centralized laboratory infrastructure. Test results are stored on the eStick and displayed on the QIAreach eHub, and the assay can be used with or without connection to a computer for optional data export to LIS.Software, user manual and ordering information